News
The combination of open-source software with artificial intelligence is opening up new possibilities for custom software ...
Julia Pottinger is the Head of Training and Development at QualityWorks with expertise in manual, automated and API testing ...
Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs through AI to treat obesity and other cardiometabolic diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results